NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q2 2026 Earnings Call Transcript May 12, 2026
NeuroOne Medical Technologies Corporation misses on earnings expectations. Reported EPS is $-0.25 EPS, expectations were $-0.22667.
Operator: Good day, ladies and gentlemen, and welcome to NeuroOne Medical Technologies Corporation’s Second Quarter Fiscal 2026 Financial Results Conference Call. Today’s call will be conducted by the company’s Chief Executive Officer, Dave Rosa; and Ron McClurg,...
